Leading the way to safer medication
 Crosscheck  Recommender

Anakinra

Description

Anakinra neutralises the biologic activity of interleukin-1α (IL-1α) and interleukin-1β (IL-1β) by competitively inhibiting their binding to interleukin-1 type I receptor (IL-1RI). Interleukin-1 (IL-1) is a pivotal pro-inflammatory cytokine mediating many cellular responses including those important in synovial inflammation.

ATC Classification

Code
Title
Category
L04AC03
Anakinra
L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AC Interleukin inhibitors

Trade names

Trade name
Countries

Australia Austria Canada Cyprus France

Product Monographs

Monograph
Type
Country
KINERET Solution for injection
MPI, EU: SmPC